Shariff Zakia, Kirby Daniel, Missaghi Shahrzad, Rajabi-Siahboomi Ali, Maidment Ian
Aston Pharmacy School, Aston University, Birmingham B4 7ET, UK.
Colorcon Inc., Harleysville, PA 19438, USA.
Pharmaceutics. 2020 Sep 23;12(10):905. doi: 10.3390/pharmaceutics12100905.
Older people represent a very heterogeneous patient population and are the major user group of medication. Age-related changes mean that this population can encounter barriers towards taking medicines orally. The aim of this study was to investigate the characteristics of oral solid dosage forms that contribute to an age appropriate dosage design, with an aim to improve overall medication adherence and acceptance in older people. Fifty-two semistructured interviews were conducted with older people, informal (family) carers, and health and social care professionals. Formulation characteristics impacted three stages of the medication taking process: (1) medication identification and memorability, (2) medication handling and (3) swallowability. Small round tablets (≤7 mm) are least accepted amongst older people and their carers and had a negative impact on all stages. The use of bright, two-coloured preparations and interesting shapes improves identification and further aids memorability of indications and the timing of tablets. Palatability, while useful to enhance swallowability, also has an impact on the visual appeal and memorability of medication. Environmental, patient, medication and disease characteristics also determine preferences for formulation. Developing an age appropriate dosage design for older people, therefore, requires a holistic, patient-centric approach to improve adherence and acceptance.
老年人是一个非常多样化的患者群体,也是药物的主要使用群体。与年龄相关的变化意味着该群体在口服药物方面可能会遇到障碍。本研究的目的是调查有助于进行适合老年人剂量设计的口服固体剂型的特征,以提高老年人对药物治疗的总体依从性和接受度。对老年人、非正式(家庭)照顾者以及健康和社会护理专业人员进行了52次半结构化访谈。制剂特性影响服药过程的三个阶段:(1)药物识别和记忆性,(2)药物处理,以及(3)吞咽性。小圆形片剂(≤7毫米)在老年人及其照顾者中最不被接受,并且对所有阶段都有负面影响。使用亮色、双色制剂和有趣的形状可改善识别,并进一步有助于记住适应症和服药时间。适口性虽然有助于提高吞咽性,但也会影响药物的视觉吸引力和记忆性。环境、患者、药物和疾病特征也决定了对制剂的偏好。因此,为老年人开发适合其年龄的剂量设计需要一种全面的、以患者为中心的方法来提高依从性和接受度。